The Fed's July Meeting Minutes Show a Growing Urgency to Raise Interest Rates. Here's Why I Still Think a 2026 Rate Hike Is Very Unlikely
Aug 19, 2026 by Steven PorrelloBloom Energy's New Product Just Made Its Biggest AI Advantage Even Stronger. Here's What Investors Need to Know.Bloom is cutting its installation time by 40%, and it could be a boon for the stock.
Aug 19, 2026 by Jeremy BowmanTarget Quarterly Profit Doubles to $1.88 Billion. Is the Turnaround Finally Taking Hold?Target's new investments are paying off as the retailer returns to steady growth.
Aug 19, 2026 by Bram BerkowitzModerna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.The treatment combines an mRNA shot with Merck's Keytruda.
Aug 19, 2026 by Joe TenebrusoWhy Moderna Stock Skyrocketed TodayThe biotech could be on the verge of setting a new standard of care for skin cancer.
Aug 19, 2026 by Christy BieberWhat Every 60-Year-Old Should Know About Social SecurityAt 60, you're close to the age when you'll claim Social Security, so it's time to start looking at the details.
Aug 19, 2026 by Eric VolkmanWhy Wheaton Precious Metals Zoomed 11% Higher TodayIts favorite commodities staged a surprise Hump Day rally.
Aug 19, 2026 by Jack DelaneyStock-Split Watch: Is Lockheed Martin Next?Consider investing in Lockheed for the long haul rather than playing a timing game with a stock split.
Aug 19, 2026 by Eric VolkmanWhy SPS Commerce Stock Was a Winner on WednesdayAn analyst raised his price target on the company by more than 33%.
Aug 19, 2026 by Robert IzquierdoAstera Labs vs. monday.com: Comparing Revenue Trends Between These High-Growth Tech CompaniesAstera Labs' quarterly revenue surpassed monday.com for the first time in Q2 2026, signaling a potential inflection in their competitive positioning.
Aug 19, 2026 by Jeff SiegelTesla's Model Y L Is Coming to America. Will It Reignite Sales Growth?The Model Y L targets a missing customer.
Aug 19, 2026 by Josh Kohn-LindquistStock Market Today, Aug. 19: Nebius Falls 10% on $4.5 Billion Convertible Note OfferingOn Aug. 19, 2026, the AI cloud provider announced a massive debt-to-equity conversion plan, triggering dilution concerns and heavy selling pressure.
Aug 19, 2026 by Sara AppinoMarvell Technology vs. Verizon Communications: Which Technology Stock Is a Better Buy in 2026?Marvell offers high-octane growth at the center of the AI chip build-out, while Verizon offers steady income and improving fundamentals for more conservative investors.
Aug 19, 2026 by Geoffrey SeilerBillionaire Stanley Druckenmiller Just Dumped Micron and Intel While Adding These 2 AI Stocks. Should Investors Follow Suit?AMD and Alphabet look like good long-term buys.
Aug 19, 2026 by Brendan CoffeyVEA vs VXUS: Does a Vanguard Developed Markets or Emerging Markets ETF Provide Better Growth Prospects?ure?VEA delivered stronger 1-year returns at 28.9% versus VXUS's 26.3%, though VXUS offers broader diversification across 8,602 holdings including emerging markets.
Aug 19, 2026 by Josh Kohn-LindquistStock Market Today, Aug. 19: Stocks Edge Higher, Ending 3-Day Losing StreakToday, Aug. 19, 2026, bond market relief halted a three-day slide, lifting interest-rate-sensitive equities and healthcare names.
Aug 19, 2026 by Bram BerkowitzThe Fed's July Meeting Minutes Show a Growing Urgency to Raise Interest Rates. Here's Why I Still Think a 2026 Rate Hike Is Very UnlikelyMinutes from the Federal Open Market Committee's July 28-29 meeting show uneasiness among members regarding inflation.
Aug 19, 2026 by Sara AppinoAdvanced Micro Devices vs. Salesforce: Which Technology Stock Is a Better Buy in 2026?AMD's AI momentum commands a premium valuation, while Salesforce's software dominance trades at a fraction of that multiple, a stark contrast that reshapes the growth-versus-value debate.
Aug 19, 2026 by Josh Kohn-LindquistStock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma DataToday, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA submission.
Aug 19, 2026 by Robert IzquierdoThe Trade Desk's Chief Legal Officer Sells 13,355 Shares Amid a Sinking Share PriceThe advertising platform provider reported a notable insider sale after shares fell to a 52-week low.
Aug 19, 2026 by David Jagielski, CPACould Eli Lilly Be Worth More Than SpaceX by the End of 2026?These two stocks both have market caps of more than $1 trillion, but Eli Lilly's valuation is supported by strong financials.
Aug 19, 2026 by Brendan CoffeyVanguard VEA vs iShares IXUS: Which International ETF Promises Better Performance in 2026?VEA targets developed markets with lower costs and stronger recent returns, while IXUS offers broader exposure to 4,476 companies including emerging markets.
Aug 19, 2026 by Leo SunSpaceX Spent $18.4 Billion in a Single Quarter -- $15.8 Billion of It on AI. Here's Where the Money Is Going.SpaceX's AI spending spree continues as it tries to achieve its ambitious goals.
Aug 19, 2026 by Brendan CoffeyKratos Defense vs. Nokia: Is Defense or Telecom a Better Stock Buy in 2026?Kratos trades at 95x forward earnings while Nokia sits at 27x, but one generates $1.7 billion in free cash flow annually and the other burned $137 million last year.
